Neil Andrew Goldenberg
Physician at Sedalia St, Denver, CO
License number
Colorado 43852
Issued Date
Aug 1, 2005
Renew Date
Jun 1, 2011
Expiration Date
Apr 30, 2013
Type
Physician
Address
Address
6493 S Sedalia St, Denver, CO 80016
Personal information
See more information about Neil Andrew Goldenberg at radaris.comName
Address
Phone
1550 Platte St, Denver, CO 80202
6493 Sedalia St, Aurora, CO 80016
1674 Cherry St, Denver, CO 80220
1550 Platte St, Denver, CO 80202
Professional information
Dr. Neil Goldenberg - MD (Doctor of Medicine)
Hospitals:
13001 E 17Th Pl, Aurora 80045
Center For Cancr and Bld Disordrs
13123 E 16Th Ave SUITE B115, Aurora 80045
University Hospital
234 Goodman St, Cincinnati 45219
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
13001 E 17Th Pl, Aurora 80045
Center For Cancr and Bld Disordrs
13123 E 16Th Ave SUITE B115, Aurora 80045
University Hospital
234 Goodman St, Cincinnati 45219
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
Center For Cancr and Bld Disordrs
13123 E 16Th Ave SUITE B115, Aurora 80045
University Hospital
234 Goodman St, Cincinnati 45219
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
13001 E 17Th Pl, Aurora 80045
Center For Cancr and Bld Disordrs
13123 E 16Th Ave SUITE B115, Aurora 80045
University Hospital
234 Goodman St, Cincinnati 45219
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
Education:
Medical Schools
McGill University Faculty Of Medicine
Graduated: 1998
McGill University Faculty Of Medicine
Graduated: 1998
Neil Andrew Goldenberg, Aurora CO
Specialties:
Pediatric Hematologist / Oncologist
Address:
13123 E 16Th Ave, Aurora, CO 80045
501 6Th Ave S, St Petersburg, FL 33701
501 6Th Ave S, St Petersburg, FL 33701
Education:
McGill University, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Methods For A Global Assay Of Coagulation And Fibrinolysis
US Patent:
2008026, Oct 30, 2008
Filed:
Sep 22, 2005
Appl. No.:
11/575853
Inventors:
Neil A. Goldenberg - Aurora CO, US
Marilyn J. Manco-Johnson - Greenwood Village CO, US
Linda Jacobson - Denver CO, US
William E. Hathaway - Denver CO, US
Marilyn J. Manco-Johnson - Greenwood Village CO, US
Linda Jacobson - Denver CO, US
William E. Hathaway - Denver CO, US
International Classification:
C12Q 1/56
US Classification:
435 13
Abstract:
The present disclosure concerns methods of analyzing both clot formation and fibrinolysis in a sample, preferably simultaneously. In certain embodiments, the methods may comprise adding a small amount of at least one activator of coagulation and at least one activator of fibrinolysis to a sample and analyzing the sample for kinetic parameters related to clot formation and fibrinolysis. In another embodiment, the methods may comprise analyzing a sample from a subject for clot formation and fibrinolysis and detecting or diagnosing a disease or condition and/or applying information obtained from analyzing clot formation and fibrinolysis to determine a treatment for a medical condition of the subject.
Compositions, Methods And Uses For Simultaneous Assay Of Thrombin And Plasmin Generation
US Patent:
2013006, Mar 14, 2013
Filed:
Nov 5, 2010
Appl. No.:
13/508341
Inventors:
Mindy Grunzke - Denver CO, US
Neil Goldenberg - Aurora CO, US
Marilyn J. Manco-Johnson - Greenwood Village CO, US
Linda Jacobson - Denver CO, US
William E. Hathaway - Denver CO, US
Neil Goldenberg - Aurora CO, US
Marilyn J. Manco-Johnson - Greenwood Village CO, US
Linda Jacobson - Denver CO, US
William E. Hathaway - Denver CO, US
Assignee:
The Regents of the University of Colorado, a body corporate - Denver CO
International Classification:
C12Q 1/56, C12M 1/34, G01N 21/64
US Classification:
435 13, 4352871
Abstract:
Embodiments of the present invention report compositions and methods of analyzing thrombin and plasmin generation in a sample from a subject. In certain embodiments, the methods may comprise introducing at least one activator of coagulation and at least one activator of fibrinolysis to a sample and analyzing the sample for kinetic parameters related to thrombin and plasmin generation. In other embodiments, assays disclosed herein concern assessing net hemostatic balance of a subject for diagnostic and/or therapeutic applications.